Matches in SemOpenAlex for { <https://semopenalex.org/work/W2954832412> ?p ?o ?g. }
- W2954832412 endingPage "5086" @default.
- W2954832412 startingPage "5077" @default.
- W2954832412 abstract "Background: Natural killer (NK) cells can be used as an adoptive immunotherapy to treat cancer patients. Purpose: In this study, we evaluated the efficacy of highly activated NK (HANK) cell immunotherapy in patients with advanced lung cancer. Patients and methods: Between March 2016 and September 2017, we enrolled 13 patients who met the enrollment criteria. Donor peripheral blood monocytes were isolated from patients and the NK cells were expanded. After 12 days of culture, the cells were collected and infused intravenously on days 13 to 15. The enrolled patients received at least one course including three times of infusions. The lymphocyte subsets, cytokine production, and the expression of carcinoembryonic antigen (CEA) and thymidine kinase 1 (TK1) were measured before treatment and after the last infusion. Results: No side effects were observed. After a three-month follow-up, the percentage of patients who achieved stable disease and progressive disease was 84.6% and 15.4%. Moreover, the level of IFN-γ was significantly higher after treatment and the level of CEA decreased substantially. The overall immune function of the patients who received the NK cell therapy remained stable. Conclusion: This is the first study to describe the efficacy of NK cell therapy of patients with advanced lung cancer. These clinical observations demonstrated that NK cell is safe and efficient for advanced lung cancer therapy." @default.
- W2954832412 created "2019-07-12" @default.
- W2954832412 creator A5004755042 @default.
- W2954832412 creator A5021163747 @default.
- W2954832412 creator A5022681647 @default.
- W2954832412 creator A5027144599 @default.
- W2954832412 creator A5050750075 @default.
- W2954832412 creator A5053308589 @default.
- W2954832412 date "2019-07-01" @default.
- W2954832412 modified "2023-10-17" @default.
- W2954832412 title "<p>Preparation of highly activated natural killer cells for advanced lung cancer therapy</p>" @default.
- W2954832412 cites W1570463153 @default.
- W2954832412 cites W1828402880 @default.
- W2954832412 cites W1970753581 @default.
- W2954832412 cites W1975938155 @default.
- W2954832412 cites W1981137720 @default.
- W2954832412 cites W1987678124 @default.
- W2954832412 cites W2004962128 @default.
- W2954832412 cites W2005765588 @default.
- W2954832412 cites W2006077585 @default.
- W2954832412 cites W201042233 @default.
- W2954832412 cites W2020181553 @default.
- W2954832412 cites W2023772537 @default.
- W2954832412 cites W2035313744 @default.
- W2954832412 cites W2036088843 @default.
- W2954832412 cites W2050749285 @default.
- W2954832412 cites W2054841768 @default.
- W2954832412 cites W2060192008 @default.
- W2954832412 cites W2070067118 @default.
- W2954832412 cites W2070120246 @default.
- W2954832412 cites W2074544778 @default.
- W2954832412 cites W2075049419 @default.
- W2954832412 cites W2082927988 @default.
- W2954832412 cites W2084848633 @default.
- W2954832412 cites W2086047092 @default.
- W2954832412 cites W2091262320 @default.
- W2954832412 cites W2091675007 @default.
- W2954832412 cites W2092215629 @default.
- W2954832412 cites W2092863058 @default.
- W2954832412 cites W2102034071 @default.
- W2954832412 cites W2103082036 @default.
- W2954832412 cites W2103822734 @default.
- W2954832412 cites W2118210558 @default.
- W2954832412 cites W2130649175 @default.
- W2954832412 cites W2140111836 @default.
- W2954832412 cites W2142379685 @default.
- W2954832412 cites W2145055473 @default.
- W2954832412 cites W2146494327 @default.
- W2954832412 cites W2148239543 @default.
- W2954832412 cites W2157742028 @default.
- W2954832412 cites W2158513713 @default.
- W2954832412 cites W2159781021 @default.
- W2954832412 cites W2161798205 @default.
- W2954832412 cites W2166856042 @default.
- W2954832412 cites W2167805334 @default.
- W2954832412 cites W2258216786 @default.
- W2954832412 cites W2272984102 @default.
- W2954832412 cites W2398741515 @default.
- W2954832412 cites W2417003620 @default.
- W2954832412 cites W2427517637 @default.
- W2954832412 cites W2565164987 @default.
- W2954832412 cites W2595057325 @default.
- W2954832412 cites W2608119321 @default.
- W2954832412 cites W2615210350 @default.
- W2954832412 cites W2748619263 @default.
- W2954832412 cites W2793972028 @default.
- W2954832412 cites W2915478882 @default.
- W2954832412 cites W2917837889 @default.
- W2954832412 cites W2990476997 @default.
- W2954832412 cites W4239706257 @default.
- W2954832412 cites W613093006 @default.
- W2954832412 doi "https://doi.org/10.2147/ott.s201924" @default.
- W2954832412 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6616273" @default.
- W2954832412 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31308687" @default.
- W2954832412 hasPublicationYear "2019" @default.
- W2954832412 type Work @default.
- W2954832412 sameAs 2954832412 @default.
- W2954832412 citedByCount "11" @default.
- W2954832412 countsByYear W29548324122019 @default.
- W2954832412 countsByYear W29548324122020 @default.
- W2954832412 countsByYear W29548324122021 @default.
- W2954832412 countsByYear W29548324122022 @default.
- W2954832412 countsByYear W29548324122023 @default.
- W2954832412 crossrefType "journal-article" @default.
- W2954832412 hasAuthorship W2954832412A5004755042 @default.
- W2954832412 hasAuthorship W2954832412A5021163747 @default.
- W2954832412 hasAuthorship W2954832412A5022681647 @default.
- W2954832412 hasAuthorship W2954832412A5027144599 @default.
- W2954832412 hasAuthorship W2954832412A5050750075 @default.
- W2954832412 hasAuthorship W2954832412A5053308589 @default.
- W2954832412 hasBestOaLocation W29548324121 @default.
- W2954832412 hasConcept C10882517 @default.
- W2954832412 hasConcept C114684123 @default.
- W2954832412 hasConcept C121608353 @default.
- W2954832412 hasConcept C126322002 @default.
- W2954832412 hasConcept C129374314 @default.
- W2954832412 hasConcept C143998085 @default.
- W2954832412 hasConcept C1491633281 @default.